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Differential Transcriptional Regulation of meis1 by Gfi1b
and Its Co-Factors LSD1 and CoREST
Asif H. Chowdhury, Johnny R. Ramroop, Ghanshyam Upadhyay, Ananya Sengupta, Anna Andrzejczyk,
Shireen Saleque*
Department of Biology, The City College of New York and The Graduate Center of The City University of New York, New York, New York, United States of America

Abstract
Gfi1b (growth factor independence 1b) is a zinc finger transcription factor essential for development of the erythroid and
megakaryocytic lineages. To elucidate the mechanism underlying Gfi1b function, potential downstream transcriptional
targets were identified by chromatin immunoprecipitation and expression profiling approaches. The combination of these
approaches revealed the oncogene meis1, which encodes a homeobox protein, as a direct and prominent target of Gfi1b.
Examination of the meis1 promoter sequence revealed multiple Gfi1/1b consensus binding motifs. Distinct regions of the
promoter were occupied by Gfi1b and its cofactors LSD1 and CoREST/Rcor1, in erythroid cells but not in the closely related
megakaryocyte lineage. Accordingly, Meis1 was significantly upregulated in LSD1 inhibited erythroid cells, but not in
megakaryocytes. This lineage specific upregulation in Meis1 expression was accompanied by a parallel increase in di-methyl
histone3 lysine4 levels in the Meis1 promoter in LSD1 inhibited, erythroid cells. Meis1 was also substantially upregulated in
gfi1b2/2 fetal liver cells along with its transcriptional partners Pbx1 and several Hox messages. Elevated Meis1 message
levels persisted in gfi1b mutant fetal liver cells differentiated along the erythroid lineage, relative to wild type. However, cells
differentiated along the megakaryocytic lineage, exhibited no difference in Meis1 levels between controls and mutants.
Transfection experiments further demonstrated specific repression of meis1 promoter driven reporters by wild type Gfi1b
but neither by a SNAG domain mutant nor by a DNA binding deficient one, thus confirming direct functional regulation of
this promoter by the Gfi1b transcriptional complex. Overall, our results demonstrate direct yet differential regulation of
meis1 transcription by Gfi1b in distinct hematopoietic lineages thus revealing it to be a common, albeit lineage specific,
target of both Gfi1b and its paralog Gfi1.
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While Gfi1 was shown to be over-expressed in chronic myeloid
leukemias in a case study in China [19], a variant of Gfi1 (S36N)
(in which the serine residue at position 36 is replaced by an
asparagine) was observed to be prevalent in AML patients in
Europe [20]. Gfi1b was earlier shown to be over-expressed in
erythroid and megakaryocytic malignancies and the proliferative
capacity of leukemic cell lines was found to be directly proportional to Gfi1b levels [21]. Full length Gfi1b and a shorter
splice variant isoform of it were also shown to be over-expressed in
AML and CML patients [18]. The shorter Gfi1b splice variant
Gfi1bp32 was also recently shown to be expressed in normal cells
and required for erythroid differentiation of a multi-potent
hematopoietic cell line [22].
Although, ablations of gfi1 and gfi1b function produce both
distinct and overlapping phenotypes, these proteins exhibit
remarkable physiological and mechanistic interchangeability
during hematopoietic development as evidenced by targeted
replacement of gfi1 with gfi1b (knock in) in the mouse genome
[23], and in the co-factors they associate with to mediate their
functions [24,25,26,27]. Knock in of the gfi1b cDNA into the gfi1
locus produced ostensibly normal hematopoietic development but
did not rescue inner ear defects ensuing from loss of gfi1 [23]. Both

Introduction
Growth factor independence (Gfi)1 and Gfi1b are homologous
zinc finger transcriptional repressors that perform critical and
essential functions in multiple developmental processes and stages.
In the hematopoietic system, Gfi1 is required for maintaining stem
cell homeostasis in the bone marrow [1,2], generating neutrophils
[3,4], and ensuring proper development and maturation of other
innate and adaptive lymphoid cells [5,6,7]. Gfi1 also controls
differentiation of non-hematopoietic tissues including inner ear
hair cells, lung, and intestine [8,9,10]. Gfi1b is essential for
generation of the definitive erythroid and megakaryocytic lineages
in the fetal liver [11]. Conditional deletion of gfi1b in adult HSCs
also perturbs quiescence, resulting in ectopic mobilization and
expansion of the HSC compartment [12].
Gfi1 and Gfi1b have also been implicated in oncogenesis. Gfi1
exhibits major oncogenic potential and has been associated with
both murine and human cancers [9,13,14,15]. Additionally, over
expression of Gfi1 co-operatively accelerates the rate of lymphomagenesis in collaboration with the oncogenes c-myc or pim1 [16].
Similar results have also been reported for Gfi1b [17]. Recent
reports also suggest a probable connection between both factors
and chronic (CML) and acute (AML) myeloid leukemias [18,19].
PLOS ONE | www.plosone.org
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with the promoter chromatin, nevertheless these results confirm
independent, lineage specific, regulation of meis1 transcription by
both Gfi paralogs. This demonstration of meis1 as a common gene
target of both Gfi1 and Gfi1b in turn underscores the functional
basis of the observed physiological interchangeability between
these proteins. Given that the fly ortholog of the Gfi proteins,
Senseless (Sens) opposes Meis/Hox function during fly neurogenesis [35], our results further demonstrate that functional antagonism between the hox and gfi/sens families has been conserved
through evolution from flies to mammals despite duplication of the
sens orthologs in the latter.

proteins also associate with the chromatin regulatory factors LSD1
(lysine specific demethylase1), CoREST/Rcor1 (REST co-repressor) and HDACs1–2 (histone deacetylases) via their N
terminal, 20 amino acid long, transcriptional repression SNAG
domains [24,27]. Recruitment of these co-factors mediates reversible transcriptional repression of Gfi1 and Gfi1b target genes.
Gfi1 and Gfi1b also associate with the histone methyl transferase,
G9a via other domains which likely mediates or initiates relatively
stable, long term silencing of their targets [25,26]. The function of
their almost identical 20 amino acid long SNAG domains is
further underscored by an amino acid substitution (proline to
alanine) at position 2 that ablates both transcriptional repression
and biological activities of both proteins albeit in distinct cellular
contexts [23,27,28,29]. Consistent with their virtually identical, C
terminal, DNA binding zinc fingers they also bind the same
consensus sequence TAAATCAC(A/T)GCA in the promoters of
their gene targets [17,30]. Thus these proteins are likely to share,
and repress, many common targets though the actual pool of
responsive targets in any cell type may be determined by cellular
context and chromatin accessibility.
Despite the diverse and essential roles of Gfi-1 and Gfi-1b,
relatively little is known regarding their mechanism of action,
particularly the identity and function of the significant gene targets
of Gfi1b and how they mediate the functions of this protein.
Therefore, we performed chromatin immunoprecipitation screens
(ChIP on chip) to identify common gene targets of Gfi1b and its
co-factors LSD1 and CoREST in erythroid cells as previously
reported, and identified 653 ChIP targets of all three proteins [27].
To determine the regulation of these targets by Gfi1b/LSD1/
CoREST, expression profiling of these genes was performed in
control versus LSD1 inhibited erythroid cells since depletion of
LSD1 had previously been shown to up-regulate known Gfi1b
gene targets (including itself) in erythroid cells [27]. The
combination of the ChIP and microarray profiling screens
revealed that the oncogene meis1 (myeloid ecotropic virus integration site1), a three amino acid loop extension (TALE) subclass
of homeodomain transcription factors, was most robustly regulated
by the Gfi1b complex, following that of its own promoter as
previously described [31].
Analysis of the ChIP sequences further demonstrated the
presence of 2 distinct meis1 promoter segments with numerous
consensus and quasi-consensus Gfi1/1b sites that were occupied
by Gfi1b, LSD1 and COREST specifically in erythroid cells but
not in megakaryocytes. Accordingly, inhibition of LSD1 in
erythroid cells but not in megakaryocytes lead to elevated Meis1
expression, and was also accompanied by elevated di-methyl H3–
K4 levels in the promoter chromatin of the of the former. Meis1
mRNA was also found to be upregulated in gfi1b2/2 fetal liver
cells relative to wild type controls, and this upregulation persisted
when these cells were differentiated along the erythroid lineage but
disappeared when cultured along the megakaryocytic lineage. The
message levels of Meis1 transcriptional partners, and other related
proteins, that are often co-ordinately upregulated with it in
different leukemias, such as Pbx1 and a number of Hox family
members [32,33] was also found to be elevated in the mutants
although to different extents. Finally, different segments of the
Meis1 promoter were observed to be repressed by Gfi1b in
reporter based transfection assays. This repression required both
the intact SNAG and DNA binding domains of Gfi1b.
Our results demonstrating direct regulation of meis1 transcription by Gfi1b complement a similar relationship between its
paralog, Gfi1 and Meis1 expression in myeloid cells [34].
Although this study neither documented direct regulation of the
meis1 promoter by Gfi1, nor association of Gfi1 and its co-factors
PLOS ONE | www.plosone.org

Materials and Methods
ChIP and ChIP on Chip
Chromatin immunoprecipitations were performed in MEL and
L8057 cells as previously described [27]. Briefly, 56107 cells were
used per ChIP reaction, crosslinked with 1% formaldehyde,
sonicated, precleared, and incubated with 5–10 mg of antibody or
pre-immune sera. Complexes were washed with low and high salt
buffers, and the DNA was extracted and precipitated. Primers
used for ChIP were as follows:
Gfi-1Bp: CGCCAGATTTTGACACAAATAA, CTGCACAGACAGACACTTCTCC.
Meis1.1: GATAATTGATTTTCCCCGCAGC, GAAAATGAGCTCACCCAAATCTC.
mMeis1.2: CTGATTTTTTTGGGGGGGAGA, CTGAGCATAAAAGCGCTCTGG.
ChIP on chip was performed as previously described [27].
Hybridization was performed on the Affymetrix GeneChip Mouse
promoter 1.0R arrays. MAT [36] was applied to predict the target
loci, and targets were predicted at the MAT p value cutoff of
1.061026. Mouse genome annotation released in March 2006
(mm8, refFlat) of genomic regions between 5 kb 59 and 2 kb 39 of
transcription start site (TSS) was searched to predict target
sequences. Microarray expression profiling was performed using
the Affymetrix Mouse Chip 430_2 array and results compared
with the CHIP on chip data.

Extract Preparation and Western Blotting
Whole cell extracts from different cell lines and Western blotting
was performed as previously described [27]. Antibodies used for
ChIP and Westerns have also been previously described [27].

RNAi and qPCR
Mel and L8057control cell lines or those stably expressing
LSD1shRNA(TGCTGTTGACAGTGAGCGCGGATGGGATTTGGCAACCTTATAGTGAAGCCACAGATGTATAAGGTTGCCAAATCCCATCCTTGCCTACTGCCTCGGA) from the retroviral vector mIR-PIG (LTRU6-Mir30-PuroIresGFP) as previously described [27] were used
for RNA extraction and qPCR. Total fetal livers were also
harvested from e12.5 mouse embryos and used for RNA
extraction. RNA was prepared from cell lines and primary cells
using the RNeasy kit (Qiagen).
QPCR (40–45 cycles per primer pair) was performed with Sybr
Green Mastermix (Applied Biosystems) in an ABI 7500 machine.
qPCR primers used were as follows:
Gfi1B: cttaccactgtgtcaagtgcaac, ctcctgtgagtggacgtgagtat.
Meis1: gccatacaagtgttaaggtttcatc, cctccttctctatcatctatcacaa.
Hoxa9: ccttatggcattaaacctgaacc, tgtttttctctatcaactggaggag,
Pbx1: ggacattttacagcaaattatgacc, cattaaacaaggcaggcttcattc,
Hoxb3: agttccacttcaaccgttatttgt, ccttctggtctttcttgtacttcat.
Hoxc4: atgatcatgagctcgtatttgatg, gactgtgttcagggatgtagctatt.
2
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Hoxd13:agctcaaagaactggagaatgagta, cttggagacgattttcttgtcct.
P values of the qPCR data were calculated using one way Anova
comparisons with Halm-Sidak post-hoc test using GraphPad
PrismTM (Version 6) software.

of Gfi1b, LSD1 and Rcor1 should be transcriptionally derepressed
in LSD1 deficient cells relative to controls, given that LSD1
functions as a transcriptional repressor in the context of Gfi1b and
CoREST [27]. Of the 653 putative targets, gfi1b itself was most
highly upregulated in LSD1 inhibited cells consistent with the
established auto-regulation of this promoter [31]. The next most
de-repressed message was found to be that of the homeo box
protein, Meis1 (Table 1).
To assess repression of meis1 by LSD1 in the context of Gfi1b,
meis1 expression and subsequent de-repression in cells deficient in
LSD1, was determined by quantitative PCR (qPCR) analysis in
the closely related erythroid and megakaryocytic lineages
(Figure 1A and B). Both gfi1b and meis1 were found to be
upregulated in erythroid (MEL) cells deficient in LSD1 relative to
controls. In contrast, meis1 was neither expressed in control, nor
upregulated upon LSD1 depletion, in the closely related megakaryocytic (platelet) lineage, L8057 cells. Given that both lineages
express high levels of Gfi1b, LSD1 and CoREST (Figure 1c) and
that gfi1b itself is upregulated upon LSD1 inhibition in both
lineages, the meis1 promoter appears to be specifically targeted for
differential regulation by Gfi1b and its co-factors in these closely
related lineages. Curiously, gene targeting experiments demonstrated an absolute requirement for meis1 in megakaryopoiesis
[39]. Therefore, the absence of Meis1 in this mouse megakaryoblastic line capable of differentiating into megakaryocytes in vitro
[27,38] along with its insensitivity to regulation by Gfi1b/LSD1/
CoREST indicates stage specific inactivation of meis1 in this
lineage.

Plasmid Construction
Gfi-1b, and P2A-Gfi-1b expression vectors were as previously
described [27], the Gfi1b-del5+6 vector was constructed by PCR
amplification of Gfi1b sequences upstream of the 5th zinc finger
(corresponding to amino acids 1–272) followed by subcloning the
product into the XbaI site of pEF1alpha. The Meis1 promoter
constructs were produced by subcloning the indicated regions of
the Meis1 promoter upstream of the luciferase gene in the pGL3
vector (Promega). The Gfi1b core promoter plasmid was a gift of
T. Moroy.

Cell Lines, Transfections and Luciferase Assays
MEL, a murine erythroleukemia cell line comprised of erythroid
precursors arrested at the proerythroblast stage [37]; L8057,
a megakaryoblastic cell line derived from a C3H/He mouse [38]
and HEK-293T (ATCC # CRL-11268TM) a transformed human
kidney cell line were cultured as previously described [27]. MEL
and L8057 cells were transduced with shRNA carrying retroviruses as indicated above.
Transfection experiments were performed with 50–70% confluent HEK-293T cells plated in wells of a 24 well plate which
were co-transfected with 1 mg of the luciferase reporter and the
indicated amounts of the expression vectors along with 50 ng of
EF4-b -gal expression vector. Cells were harvested 48 hrs after
transfection and lysed in 100 ml of CCLR lysis buffer (Promega).
20 ml of lysate was mixed with 100 ml of luciferase assay reagent
(Promega) and luminescence measured on a GlorunnerTM microplate luminometer (Turner Biosystems).

Differential meis1 Promoter Occupancy and Chromatin
Status in Erythroid Versus Megakaryocytic Cells
The original ChIP on chip experiments identified two distinct
,1.2 kb long Meis1 promoter segments that hybridized to DNA
sequences selectively enriched in Gfi1b/LSD1/CoREST immunopecipitates relative to immunoglobulin controls in MEL cells
(Figure 2A). Both of these contained putative consensus and quasiconsensus Gfi1/1b binding sites. To define the locations of the
Gfi1b, LSD1 and CoREST associated sites on the meis1 promoter,
ChIP experiments were conducted in MEL and L8057 cells.
Although, the Meis1 promoter exhibits multiple distinct transcriptional start sites (tss), the majority of these transcripts originate at
or near the point corresponding to the 59 end of the mRNA
designated NM_010789 in the NCBI data base. Therefore, for
clarity we considered the 59 end of NM_010789 as a representative
tss and designated the ChIP sequences as distal (Meis1.1) and
proximal (Meis1.2) relative to it. Although, we did not verify the
actual tss for meis1 in hematopoietic cells, we observed that both
regions of the putative meis1 promoter were occupied by Gfi1b,
LSD1 and CoREST in MEL cells (Figure 2b). Of the two, the
distal putative non-transcribed promoter region exhibited relatively greater affinity for Gfi1b/LSD1/CoREST compared to the
proximal site, which overlapped with the transcribed region of the
gene. However, at both sites, the pattern of enrichment of the
promoter sequences in the immunoprecipitates exhibited a similar
trend. Promoter sequence enrichment was highest for Gfi1b
immunoprecipitates consistent with its direct binding to its specific
DNA recognition element, intermediate for LSD1 and lowest for
CoREST, reflecting the likely order in which these co-factors bind
to DNA or chromatin via interaction with Gfi1b. Gfi1b recruits
LSD1 to chromatin via its SNAG domain, which in turn associates
with and brings CoREST to the locus [27].
In sharp contrast to erythroid cells, but consistent with the
insensitivity of its promoter to LSD1 levels, neither region of the
meis1 promoter was occupied by any of these three factors in

Animal Welfare and Euthanasia
Animals (mice) were housed and bred in the CCNY vivarium
(The City College/CUNY Medical School Institutional Animal
Care and Use Committee number: A3733-01) as per the PIs
approved animal protocol (#0858) and in accordance with USDA
and institutional guidelines. For collection of embryos, pregnant
female mice were euthanized by asphyxiation with carbon dioxide,
delivered at less than 5psi per second. This study was approved by
The City College IACUC.

Harvesting and Culture of Fetal Liver Cells
Fetal liver cells were harvested from e12.5 embryos whose
genotypes was confirmed as previously described [11]. Livers were
dissociated by passaging through a 25G needle and syringe and
,105 cells were plated in IMDM medium with 20%FCS,
supplemented with either 2 U/ml of erythropoietin and 20 ng/
ml of SCF (stem cell factor) or with 20 ng/ml of thrombopoietin
and 10 ng/ml of IL-3 and cultured for 5 days, followed by
harvesting for total RNA.

Results
Lineage Specific meis1 Regulation by LSD1
Chromatin immunoprecipitation screens (ChIP on chip) for
common gene targets of Gfi1b, LSD1 and CoREST in erythroid
cells revealed several (653) potential common transcriptional
targets of all three factors [27]. To further investigate regulation of
these targets in erythroid cells, expression profiling was performed
in control versus LSD1 inhibited MEL (murine erythroleukemia)
cells. The rationale for the screen being that the common targets
PLOS ONE | www.plosone.org
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Table 1. Microarray profiling of Gfi1b and Meis1 expression in erythroid (MEL) cells upon LSD1 inhibition.

Gene

EX (lsd kd)

Fold increase

Accession
No.

gfi1b

3.340036542

10.1

NM_008144

Growth factor independence 1b

meis1

2.927793305

7.63

NM_010789

Myeloid ecotropic viral integration site 1

Full Name/Brief description

Increase in mRNA levels of Gfi1b and Meis1 (fold increase) in LSD1 depleted MEL cells relative to controls.
doi:10.1371/journal.pone.0053666.t001

12.5 of embryonic development (e12.5), since fetal livers consist
mainly of erythroid progenitors in early and intermediate stages of
differentiation at this age of embryogenesis [40]. Meis1 expression
was found to be reciprocal to that of Gfi1b in e12.5 fetal liver cells,
being significantly over-expressed in the mutants and slightly overexpressed in heterozygotes compared to wild type litter mates
(Figure 4A).
Furthermore, even though haploinsufficiency of gfi1b consistently produced an ,2 fold increase in Meis1 message in gfi1b+/2
fetal livers (Figure 3A), this change in the level of Meis1 did not
appear to produce any discernible phenotype in either fetal liver,
or subsequent stages, of murine hematopoiesis [11]. To investigate
lineage specific repression of the meis1 promoter in primary cells,
e12.5 fetal liver cells were differentiated along the erythroid or
megakaryocytic lineages ex vivo by being cultured in erythropoietin
(epo) and SCF or thrombopoietin (tpo) and IL-3 respectively, for 5
days (Figure S1). Interestingly, mutant cells cultured under
erythroid conditions (with epo and SCF) continued to exhibit
elevated meis1 levels relative to controls (wild type or heterozygotes) although there was some diminution in the relative levels
upon culture, probably due to the mutant cells adopting
alternative cell fates (Figure 4B). In sharp contrast, progenitors
from the same fetal livers, cultured under megakaryopoietic
conditions (with tpo and IL-3) showed either no difference in
relative meis1 levels between control and mutant cells or even
a slight decrease in the latter (Figure 4B). This proves that in
primary cells, like in cell lines, meis1 is selectively repressed only in
erythroid cells by Gfi1b and not in megakaryocytes. Therefore,

L8057 cells (Figure 2C) even though all three proteins were
present in (Figure 1C), and associated with the gfi1b promoter
(Figure 2C), in these cells. Therefore, the meis1 promoter appears
to be inaccessible to these factors at the megakaryoblast and
subsequent stages of development of this lineage despite comparable levels of all three factors in both cell types (Figure 1C).
In order to investigate the chromatin condition of the meis1
promoter in the two lineages, particularly the methylation status of
the H3–K4 residue, a substrate of LSD1 [27], in promoter
associated chromatin, CHIP experiments were performed in both
lineages. Both the gfi1b and meis1 promoters showed comparable
enrichment of di-meH3–K4 in MEL cells and further enhancement of this modification upon LSD1 inhibition (Figure 3A and
data not shown). However in L8057 cells, the gfi1b promoter
showed ,10 fold greater di-meH3–K4 enrichment compared to
the meis1 promoter (not shown) which was further enhanced upon
LSD1 depletion, while di-meH3–K4 levels at the meis1 promoter
remained very low and essentially unaltered upon LSD1 knock
down (Figure 3B). These results confirm the silent and unresponsive state of the meis1 promoter in L8057 cells, though the
mechanism(s) responsible for it, and for precluding the recruitment
of the Gfi1b protein complex to it in megakaryocytes, remain to be
determined.

Lineage Specific Deregulation of meis1 upon Loss of
Gfi1b
To confirm that meis1 is a bona fide target of, and is regulated
by, Gfi1b in vivo, its relative expression level was determined in
wild type, heterozygous and gfi1b mutant fetal liver cells at day

Figure 1. Message levels of Gfi1b and Meis1 in erythroid and megakaryocytic cells. Quantitative PCR (qPCR) of relative Gfi1b and Meis1
mRNA levels (normalized for HPRT) in (A) MEL (erythroid) and (B) L8057 (megakaryocytic) cells transduced with empty vector (mIR-PIG) or LSD1 shRNA
(LSD1 k/d). Average of three experiments is shown, error bars represent standard deviation. C. Steady state protein levels of Gfi1b, LSD1 and CoREST
relative to b-actin in HEK-293T, MEL and L8057 cells.
doi:10.1371/journal.pone.0053666.g001
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Figure 2. Occupancy of two distinct promoter regions of the meis1 promoter by Gfi1b/LSD1/CoREST. A. 2.1 kb sequence of the murine
Meis1 promoter and ,0.75 kb of coding sequence spanning the two ,1.2 kb segments (denoted in black uppercase lettering) obtained from ChIP
on chip screening for Gfi1b/LSD1/CoREST targets. Intervening and downstream sequences not obtained from ChIP are indicated in grey lowercase
letters. The putative transcriptional start site (indicated as +1 in the sequence) as inferred from the meis1 transcript sequence (NM_010789) reported
in the nucleotide database (also see text) and the initiator codon, (also according to the database) are indicated in green. The Gfi1b consensus
elements are highlighted in bold maroon lettering. Sequences of primers used for ChIP qPCR or for amplification of promoter segments for
subcloning are underlined (see also Materials and Methods). B,C. Chromatin immunoprecipitation (ChIP) analysis of the Gfi1b promoter and two
Meis1 promoter segments (Meis1.1: distal; relative to tss and Meis1.2: promoter proximal) in erythroid and megakaryocytic lineages. Enrichment of
the indicated promoter sequences relative to the immunoglobulin switch m (Sm) sequence in MEL (B) and L8057 (C) cells are indicated. Results shown
are the average (solid bars) and standard deviations (error bars) of three independent experiments.
doi:10.1371/journal.pone.0053666.g002

and collaborates with them in accelerating leukemogenesis
[33,41]. Moreover, Meis1, Hoxa9 and Pbx1 were also recently
demonstrated to be upregulated in gfi1 mutant bone marrow
myeloid progenitors resulting in their hyper-proliferation [34].
These observations prompted an assessment of message levels of
pbx1 and certain hox genes in e12.5 day fetal livers from wild type,
heterozygous and gfi1b2/2 embryos. Specifically, the relative
expression of messages encoding proteins known to either associate

although meis1 is expressed in primary megakaryocytic cells, its
expression appears to be independent of Gfi1b.

Deregulation of Hox Genes and pbx1 in gfi1b Mutants
Meis1 is often co-ordinately over-expressed in various leukemias
with its transcriptional partners the TALE domain protein Pbx1
and one or more homeodomain containing Hox family members,

PLOS ONE | www.plosone.org
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Figure 3. Di-methyl H3–K4 levels in meis1 promoter chromatin. Chromatin immunoprecipitation (ChIP) analysis of the gfi1b promoter and
two meis1 promoter segments as indicated Figure 2A in erythroid and megakaryocytic lineages. Relative enrichment of the indicated promoter
sequences for di-methyl H3–K4 in control (scrambled) versus LSD1 knocked down cells was calculated relative to that for immunoglobulin switch m
(Sm) sequences in MEL (A) and L8057 (B) cells respectively. Results shown are the average (solid bars) and standard deviations (error bars) of three
independent experiments.
doi:10.1371/journal.pone.0053666.g003

directly with Meis1 (Pbx1, Hoxa9 and Hoxb3) [33] or hox
members known to be expressed in hematopoietic stem cells/
progenitors during normal development (Hoxc4) [42] or ectopically expressed upon undergoing translocations in leukemias
(Hoxd3) [43], from multiple hox clusters were interrogated. These
messages exhibited substantial (Pbx1) to moderate (Hoxa9) to
modest and consistent (Hoxb3, Hoxc4 and Hoxd13) upregulation
in gfi1b2/2 fetal livers relative to controls (Figure 4C). Since the
pbx and hox gene promoters were not identified in the original
ChIP screen, the mechanism responsible for the observed
deregulation of these proteins in the absence of Gfi1b in fetal
liver cells i.e either by loss of direct binding and de-repression of
their promoters in gfi1b2/2 cells or by other indirect means,
remains to be determined.

Repression of the Isolated meis1 Promoter by Gfi1b
To demonstrate direct Gfi1b specific repression of the isolated
meis1 promoter by Gfi1b, luciferase reporter based promoter assays
were performed in the non-hematopoietic human embryonic
kidney cell line HEK-293T. This line does not express any
endogenous Gfi1 or Gfi1b but does express the relatively
ubiquitous co-factors LSD1 and CoREST (Figure 1C). Two
segments of the meis1 promoter comprising 2.4 kb (Meis1L) and
1.2 kb (Meis1S) of sequences upstream of the initiator ATG codon
(Figure 2A) were both repressed by Gfi1b in a dose dependent
manner, but neither by the SNAG domain mutant P2A-Gfi1b nor
(in case of meis1S) by the DNA binding deletion mutant Gfi1bdel5+6 which lacks the 5th and 6th zinc fingers (Figure 5), despite
comparable expression of all recombinant proteins in these cells
(Figure S2). These results shows that the isolated meis1 promoter is
repressed by Gfi1b in a SNAG domain and DNA binding
dependent manner. Interestingly, despite the presence of multiple

Figure 4. Message levels of Meis1, Pbx1 and Hox family members in fetal liver cells. A. QPCR of relative Gfi1b and Meis1 mRNA levels
(normalized for HPRT) in embryonic day 12.5 (e12.5) wild type, gfi1b+/2 and gfi1b2/2 fetal liver cells. B. QPCR of relative Meis1 mRNA levels
(normalized for HPRT) in control (wild type or gfi1b+/2) and gfi1b2/2 fetal liver cells differentiated along the erythroid or megakaryocytic lineages
ex-vivo. C. QPCR of relative Hoxa9, Pbx1, Hoxb3, Hoxc4 and Hoxd13 message levels from total fetal liver cells of the indicated genotypes. Averages
and standard deviations from multiple embryos of different genotypes from three cohorts are shown. The p values for Pbx1, Hoxb3 and Hoxc4 levels
in wild type versus mutant cells were ,0.001 and those for Hoxa9 and Hoxd13 were ,0.01. All values ,0.05 were considered significant.
doi:10.1371/journal.pone.0053666.g004
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consensus Gfi1b binding elements, the Meis1 promoter appeared
to be somewhat less responsive to Gfi1b protein levels relative to
the 500 bp gfi1b core promoter itself (Figure 5) that had previously
been shown to be auto- and cross- regulated by Gfi1b and Gfi1
respectively [31]. The gfi1b core promoter was maximally
repressed by 50 ng of Gfi1b while the meis1 promoter was only
partially repressed by the same level of Gfi1b and needed five fold
more Gfi1b to be completely repressed. This difference in the dose
responsiveness of the two promoters toward Gfi1b protein levels
may reflect their relative sensitivity in vivo to Gfi1b concentrations
and is also consistent with the difference in their level of
upregulation upon LSD1 inhibition in erythroid cells (Figure 1A).
Although repression of the isolated meis1 promoter by Gfi1 has not
been similarly demonstrated in reporter assays, we predict that
given the similarities between Gfi1 and Gfi1b wrt to sequence and
binding site specificities [17], the results should be very similar.
However, simply expression of one or both of these paralogs in any
cell type, may not guarantee transcriptional regulation of meis1 by
them.

fetal liver cells may appear paradoxical at first pass. However,
a recent study demonstrating the ability of Meis1 to promote
megakaryopoiesis at the expense of erythropoiesis in bone marrow
MEPs [44], suggests the probability of a similar scenario in the
fetal liver. Therefore, Gfi1b mediated repression of meis1 in fetal
liver MEPs likely ensures the channeling of the majority of these
cells into the erythroid lineage, thereby ensuring the appropriate
developmental stage specific equilibrium between these two
lineages in this organ. Interestingly, our results demonstrate that
the meis1 promoter is refractile to Gfi1b and its cofactors in
megakaryocytes despite high levels of the latter in this lineage.
How the Gfi1b transcriptional complex is either specifically
excluded from the meis1 locus in megakaryocytes or conversely is
selectively recruited to it in erythroid cells remains to be
determined. In any case, our identification of meis1 as a crucial
transcriptional target of Gfi1b complements a previous study
documenting regulation of meis1 by its paralog Gfi1 [34], and
establishes it as a common target of both Gfi proteins in
hematopoiesis. Identification of meis1 as a common gene target
of both Gfi1 and Gfi1b coupled with their association with several
common co-factors (LSD1, CoREST, HDACs etc.) [27] further
augments the mechanistic basis for the observed physiological
interchangeability between these factors during hematopoietic
development [23].

Discussion
The results presented above demonstrate that the oncogene
meis1 is a bonafide target of Gfi1b and is repressed by this factor
in vitro and in vivo. Since Gfi1b is required for both definitive
erythropoiesis and megakaryopoiesis [11], and Meis1 for megakaryopoiesis in the fetal liver [39], repression of meis1 by Gfi1b in

Figure 5. Regulation of the isolated meis1 promoter by exogenous Gfi1b. Luciferase reporter based promoter assays in HEK-293T cells. 1 mg
of reporter plasmid along with the indicated amount of expression plasmid and 50 ng of b-galactosidase expression vector was transfected into ,106
cells and assayed for luciferase activity. The 0.5 kb gfi1b core promoter was used as a positive control. The meis1L promoter consisted of 2.7 kb of
promoter sequence from 22.1 kb to +0.65 kb (see Figure 2A) and the meis1S consisted of 1.25 kb of promoter sequence from 20.60 kb to +0.65 kb
relative to the tss of meis1. P2A-represents the P2A-Gfi1b SNAG domain mutant; Gfi1b-del5+6-represents the Gfi1b deletion mutant lacking zinc
fingers 5 and 6. For each promoter set, values shown are relative to that obtained in the absence of the corresponding expression vector, following
normalization of all luciferase values for b-galactosidase levels. The average (solid bars) and standard deviations (error bars) from 3 independent
experiments is shown.
doi:10.1371/journal.pone.0053666.g005
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Figure 6. Bimodal mechanism of cell cycle inhibition by Gfi proteins. Transition from proliferation to commitment and/or differentiation
(black arrow) follows an increase in Gfi1/1b concentration (‘‘low’’ versus ‘‘high’’, as indicated by increased shading). Increasing concentrations of Gfi1/
1b repress meis/hox/pbx transcription and as levels of the latter decline (fading shapes) they may also be replaced on putative common promoters by
Gf1/1b repressive complexes resulting in transcriptional inhibition of target genes. Ectopic expression of Meis/Hox/Pbx proteins in leukemias (grey
arrow) may produce the opposite effect and reverse the normal differentiation program.
doi:10.1371/journal.pone.0053666.g006

TAAATCAC(A/T)GCA [17,30]. Thus, similar competition
between Gfi1/1b and Hox/Meis1/Pbx1 for binding to gene
regulatory elements in the mammalian genome is a likely
possibility if these binding sites or loci are accessible to, or
otherwise able to recruit, these opposing sets of factors. Therefore,
we hypothesize that Gfi1/1b may antagonize Hox/Meis/Pbx
function in mammals in a bimodal manner by simultaneously or
sequentially binding to and reducing the transcription of Hox,
Meis1 and Pbx1 factors while also stoichiometrically displacing
them from other downstream targets common to both sets of
proteins (Figure 6). Since Hox/Meis/Pbx proteins recruit
CBPp300, a histone acetyl transferase, to their target sites thereby
activating their transcription [46], the displacement of these
activating complexes with the repressive Gfi/LSD1/CoREST/
HDAC complex(es) on the promoters of cell cycle promoting genes
likely initiates the transition from proliferation to commitment
and/or differentiation of progenitors poised for maturation along
different lineages. Conversely, in leukemias, ectopic over-expression of wild type or fusion Meis/Hox/Pbx proteins may displace
Gfi1/1b repressive complexes from the promoters of such genes
leading to their over-expression (Figure 5). Although several
known Hox/Meis/Pbx targets such as Pim1, c-myb, c-myc, CD34,
flt3 and cycD [34,41] could likely mediate this effect, the
verification of the above model requires either demonstration that
the above genes are also common targets of Gfi1/1b and/or the
identification and characterization of other similar common
transcriptional targets. If this bimodal mechanism of regulation
is, in fact, observed in mammals and not in flies then it would
represent an additional level of fine tuning gene expression by Gfi
proteins that was acquired during mammalian evolution.

Increasing Complexity of Hox/Meis/Pbx and Gfi1/1b
Interactions During Evolution
Recently, functional antagonism was uncovered between the fly
ortholog of the Gfi proteins, Sens and those of Meis1 (Homothorax; Hth) and its Hox partners during fly neurogenesis [35].
This antagonism was further demonstrated to be conserved
between Gfi1 and Meis1/Hoxa9/Pbx1 in mammalian hematopoiesis although the underlying mechanism was found to be
different [34]. Our results now reiterate the conservation of this
antagonism between the Meis/Hox/Pbx conglomerate and both
Gfi paralogs during evolution from flies to mammals, despite the
complex lineage diversification associated with mammalian
hematopoiesis.
However, the molecular mechanism underlying sens/Gfi and
Meis/Hox/Pbx antagonism has undergone a major modification
from flies to mammals. In mammals, expression of the hox and
meis1 genes themselves have come under direct or indirect Gfi1/1b
regulation, while in flies Sens and Hox/Meis complexes compete
for binding to overlapping sequences in the promoters/enhancers
of common target genes and accordingly repress or activate their
transcription respectively, as demonstrated recently for the
regulation of the rhomboid (rho) enhancer [35]. Whether this
apparently newly acquired mode of meis1/hox repression by Gfi1/
1b simply supplements and/or partially or entirely supplants
physical competition between these proteins for binding to
overlapping DNA recognition elements at common potential
targets in the mammalian genome remains to be determined.
Interestingly, the Sens and Gfi1/1b binding elements have been
conserved between flies and mammals [45]. Moreover, analogous
to the sequence overlap between the Sens and Hox/Hth binding
sites in the rhomboid (rho) enhancer [35], the consensus Gfi1/1b and
Hox/Meis1/Pbx1 binding sites that have been characterized in
their respective mammalian targets also exhibit substantial
sequence overlap [17,30,32]. Interestingly, the Hoxa9/Meis1/
Pbx1 core consensus motif ATGATTTATGGC [32] that was
recently shown to be present on the majority of Hoxa9/Meis1
gene targets obtained by ChIP-Seq screening [46] is a perfect
reverse complement of the core Gfi1/1b consensus motif
PLOS ONE | www.plosone.org

Dual Roles of Gfi1/1b in Hematopoiesis
Over-expression of Gfi1 and Gfi1b have been observed in
induced and naturally occurring lymphoid and myeloid leukemias
in mice and humans respectively [9,13,14,15,16,17,18,19,21].
However, the causal role of these genes if any in initiation or
maintenance of these leukemias is not clear. In contrast, the results
presented here in combination with recent evidence [34,47]
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indicate that Meis1 and its oncogenic partners Pbx1 and Hoxa9
are actively repressed by both Gfi1 and Gfi1b in multiple lineages
and demonstrate that these proteins indeed exhibit growth
inhibitory, tumor suppressor-like properties. Accordingly, deletion
of either gfi1 or gfi1b results in hyper-proliferation of hematopoietic
stem and progenitor cells [1,2,3,4,11]. Moreover, recently
a hypomorphic mutant of gfi1 was found to be responsible for
predisposing individuals bearing this mutation to AML by
deregulating Hoxa9 expression in their myeloid cells [47]. This
same mutant was also found to collaborate with K-RAS in
inducing fatal myeloproliferative disease in mice [47]. Therefore,
these erstwhile ‘‘oncogenes’’ seem to function more like tumor
suppressors under normal circumstances, and their oncogenic
propensities if any, may be exposed upon corruption of their
normal function, perhaps under the influence of other oncogenes,
during leukemogenesis.
In conclusion, this study demonstrating the repression of the
meis1 promoter in a lineage specific manner by Gfi1b establishes
this oncogene as a crucial common target of mammalian Gfi
proteins. These results together with that demonstrating antagonism between their orthologs in flies [35], highlights an
evolutionarily ancient mechanism for regulating gene expression
that has been essentially conserved from flies to mammals while
acquiring increased sophistication and complexity in the latter, in
accordance with their expanded lineage repertoires.

e12.5 fetal liver cells from wild type and mutant embryos as
indicated, cultured with epo and SCF (top panel) or tpo and IL-3
(bottom panel). Erythroid differentiation is indicated by the
presence of small differentiated erythrocytes in the top left image,
while megakaryocytic differentiation is evidenced from the
presence of large megakaryocytes in the bottom left image.
gfi1b2/2 mutants do not give rise to either lineage [11].
(TIF)
Figure S2 Expression of recombinant proteins in 293T
cells. Western blot showing expression of the indicated
recombinant proteins following transfection of their expression
vectors into 293T cells. ,60 mg of total protein from whole cell
lysates was loaded in each lane.
(TIF)
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